The 13.3M share redemption (likely >50% of public float) signals severe lack of confidence in OAC's deal prospects. Monitor the October 16 vote outcome and any subsequent announcement of a target business combination. If the extension fails, OAC will liquidate, making the stock worth its trust value per share (~$10.00).
Price Chart
Executive Summary
Oaktree Acquisition Corp. III Life Sciences filed a DEFA14A disclosing preliminary redemption results ahead of its October 16, 2026 shareholder meeting to vote on extending the deadline to complete a business combination. 13,326,977 Class A ordinary shares were tendered for redemption, representing a significant majority of public shares, and the Sponsor intends to convert 4,798,758 Class B shares into Class A shares prior to the extension. The high redemption rate signals substantial shareholder skepticism about the SPAC's ability to consummate a deal, and the conversion ensures the Sponsor retains voting control post-redemption.
Key Financial Metrics
Key Facts
- 13,326,977 Class A ordinary shares were tendered for redemption as of the October 14, 2026 deadline.
- Post-redemption and conversion, OAC will have 11,254,791 Class A and 1,000 Class B shares outstanding.
- Sponsor will convert 4,798,758 Class B shares into Class A shares prior to the extension, holding 5,382,739 Class A shares total.
- Shareholder meeting to vote on extension proposal is scheduled for October 16, 2026.
- Without extension approval, OAC would be forced to liquidate.
Financial Impact
13.3M shares redeemed at ~$10.00 per share from trust implies ~$133M outflow, leaving roughly $112M in trust for remaining public shares and warrants.
Risk Factors
- Extension proposal may fail if insufficient votes are cast, triggering liquidation.
- High redemption rate leaves limited trust capital for any future business combination.
- Sponsor conversion does not add new capital to the trust, only shifts voting power.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-422266 |
| Document: 0001193125-26-422266-index-headers.html | 0001193125-26-422266 |
| Document: 0001193125-26-422266-index.html | 0001193125-26-422266 |
| Document: 0001193125-26-422266.txt | 0001193125-26-422266 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 8-K | $10.71 | awaiting T+1 | — | $10.68 (+0.28%) |
Oct 16, 2026 11d ago | DEFA14A | $10.70 $10.65 | ▲ +0.47% | ▲ +0.89% | $10.68 (+0.19%) |
Oct 16, 2026 11d ago | 8-K | $10.70 $10.65 | ▲ +0.47% | ▲ +0.89% | $10.68 (+0.19%) |
Oct 15, 2026 12d ago | DEFA14A | $10.65 $10.70 | ▼ −0.47% | ▼ −1.58% | $10.68 (−0.28%) |
Oct 15, 2026 12d ago | 8-K | $10.65 $10.70 | ▼ −0.47% | ▼ −1.58% | $10.68 (−0.28%) |
Oct 2, 2026 25d ago | DEF 14A | $10.76 $10.76 | · 0.00% | ▼ −0.55% | $10.68 (−0.74%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers